Why the hell does anyone want this shit Judge to add material? She messed up and she will address it while giving more information as to why the mess up was inconsequential. Do you think she is willing to admit she made the wrong decision?
Dragging out the appeal as long as possible is the best thing AMRN can do. If the generics come on the market they will have to post a bond to get an injunction filed. Even with tied up capital, the injunction should be relatively low since the expanded usage can't be claimed as damages by the generics.
Sorry to say but this will drop hard near term with the earliest catalyst being a generic approval with the FDA, which will jump back to new highs when the injunction is approved. Although something is strange here, Hikma had ANDA approval within 3 days of the courts patent ruling of zytiga https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208339Orig1s000ltr.pdf
News 
Market Data 
Discover 
